Community Health Health & Fitness News Preventive Healthcare CMS Gains China Approval for Ruxolitinib Cream, A Breakthrough in Vitiligo Treatment April 2, 2026 Farihin Azlan China Medical System Holdings Limited (CMS) has announced that its subsidiary, Dermavon Holdings Limited, has received New Drug Application (NDA) approval from the National Medical Products Administration (NMPA) of China…